Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Daiichi Sankyo
Mallinckrodt
Fuji
QuintilesIMS
Medtronic
Colorcon
AstraZeneca

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200177

« Back to Dashboard

NDA 200177 describes DIETHYLPROPION HYDROCHLORIDE, which is a drug marketed by Lannett Co Inc, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, and Watson Labs, and is included in ten NDAs. It is available from eleven suppliers. Additional details are available on the DIETHYLPROPION HYDROCHLORIDE profile page.

The generic ingredient in DIETHYLPROPION HYDROCHLORIDE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
Summary for 200177
Tradename:DIETHYLPROPION HYDROCHLORIDE
Applicant:Lannett Co Inc
Ingredient:diethylpropion hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 200177
Medical Subject Heading (MeSH) Categories for 200177
Suppliers and Packaging for NDA: 200177
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 200177 ANDA Lannett Company, Inc. 0527-1475 N 0527-1475-01
DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 200177 ANDA Aidarex Pharmaceuticals LLC 53217-230 N 53217-230-14

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Jul 18, 2011TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
UBS
McKinsey
Federal Trade Commission
Medtronic
Teva
Deloitte
Cipla
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.